Hemorrhagic and thrombotic complications in patients with myeloproliferative diseases

Authors

  • Carla Valladares Vignal Universidade Federal de São Paulo
  • Dayse Maria Lourenço Universidade Federal de São Paulo
  • Maria Aparecida Eiko Noguti Universidade Federal de São Paulo
  • Maria de Lourdes Ferrari Chauffaille Universidade Federal de São Paulo
  • José Kerbauy Universidade Federal de São Paulo

Keywords:

Myeloproliferative Diseases, Hemorrhage, Thrombosis, Bleeding time, Platelet aggregation

Abstract

OBJECTIVE: To correlate the incidence of hemorrhage and thrombosis to bleeding time (BT) and platelet aggregation in 27 consecutive patients with myeloproliferative diseases (MPD). DESIGN: Retrospective study. SETTING: Public tertiary referral center. PATIENTS: Eighteen patients with chronic myelogenous leukemia (CML), 5 with polycytemia vera (PV), 2 with essential thrombocytemia (ET) and 2 with idiopathic myelofibrosis (MF). Duke's BT and epinephrine-induced platelet aggregation were performed on the patients and on 10 healthy individuals. RESULTS: Eleven patients presented symptoms (41 %): 9 with hemorrhage (33%) and 5 with thrombosis (19%).There were less symptomatic patients in the CML group (28%) than in the other MPD (67%), without statistical significance (Fisher, p=0.06). Duke's BT was longer in symptomatic patients (Mann-Whitney, p<0.05). Platelet aggregation was abnormal in 7 patients (26%) and 71% of them were symptomatic (Fisher, p = 0.07). CONCLUSIONS: The high incidence of bleeding and thrombosis in patients with MPD was related to prolonged BT, but not to platelet aggregation abnormalities.

Downloads

Download data is not yet available.

Author Biographies

Carla Valladares Vignal, Universidade Federal de São Paulo

Universidade Federal de São Paulo, Escola Paulista de Medicina, Department of Hematology, São Paulo, São Paulo, Brazil.

Dayse Maria Lourenço, Universidade Federal de São Paulo

Universidade Federal de São Paulo, Escola Paulista de Medicina, Department of Hematology, São Paulo, São Paulo, Brazil.

Maria Aparecida Eiko Noguti, Universidade Federal de São Paulo

Universidade Federal de São Paulo, Escola Paulista de Medicina, Department of Hematology, São Paulo, São Paulo, Brazil.

Maria de Lourdes Ferrari Chauffaille, Universidade Federal de São Paulo

Universidade Federal de São Paulo, Escola Paulista de Medicina, Department of Hematology, São Paulo, São Paulo, Brazil.

José Kerbauy, Universidade Federal de São Paulo

Universidade Federal de São Paulo, Escola Paulista de Medicina, Department of Hematology, São Paulo, São Paulo, Brazil.

References

Schafer AI - Bleeding and thrombosis in the myeloproliferative disorders. Blood 1984 64:1-12.

Holme S & Murphy S - Platelet abnormalities in myeloproliferative disorders. Clin Lab Med 1990;10:873-888.

Hyun BH, Gulati GL, Ashton JK - Myeloproliferative disorders. Classification and diagnostic features with special emphasis on chronic myelogenous leukemia and agnogenic myeloid metaplasia. Clin Lab Med 1990;10:825-838.

Bowie EJW & Owen Jr CA - Clinical and laboratory diagnosis of hemorrhagic disorders. In: Ratnoff OD & Forbes CD, eds. - Disorders of Hemostasis. Philadelphia: W.B.Saunders Company, 1991:48-74.

Bohr GVR - Quantitative investigations into the aggregation of blood platelets. J Physiol 1962;162:67-68.

Adams T, Schutz T, Goldberg L - Platelet function abnormalities in the myeloproliferative disorders. Scand J Haematol 1974;13:215-224.

Buss DH, Stuart JJ, Lipscomb GE - The incidence of thrombotic and hemorrhagic disorders in association with extreme thrombocytosis: an analysis of 129 cases. Am J Haematol 1985;20:365-372.

Walsh PN, Murphy S, Barry WE - The role of platelets in the pathogenesis of thrombosis and hemorrhage in patients with thrombocytosis. Thrombos Haemostas 1977;38:1085-1096.

Ginsburg AD - Platelet function in patients with high platelet counts. Ann Intern Med 1975;82:506-511.

Waddell CC, Brown JA, Repinecz YA - Abnormal platelet function in myeloproliferative disorders. Arch Pathol Lab Med 1981;105:432-435.

Zucker S & Mielke CH - Classification of thrombocytosis based on platelet function tests: correlation with hemorrhagic and thrombotic complications. J Lab Clin Med 1972;3:385-394.

Barbui T, Cortelazzo S, Viero P, Bassan R, Dini E, Semeraro N - Thrombohaemorrhagic complications in 101 cases of myeloproliferative disorders: relationship to platelet number and function. Eur J Cancer Clin Oncol 1983;19:1593-1599.

Ramam BKS, Van Slyck EJ, Riddle J, Sawdyk MA, Abraham JP, Saeed SM - Platelet function and structure in myeloproliferative disease, myelodysplatic syndrome, and secondary thrombocytosis. Am J Clin Pathol 1989;91:647-655.

Pareti FI, Gugliota L, Manucci L, Guarini A, Manucci PM - Biochemical and metabolic aspects of platelet dysfunction in chronic myeloproliferative disorders. Thromb Haemostasis 1982;47:84-89.

Boneu B, Nouvel C, Sie P, Caranobe C, Combes D, Laurent G, Pris J, Bierme R - Platelets in myeloproliferative disorders I. A comparative evaluation with certain platelet function tests. Scand J Haematol 1980;25:214-220.

Cunietti E, Gandini R, Mascaro G, Ferrari M, Pappalepore V, Scapellato L - Defective platelet aggregation and increased platelet turnover in patients with myelofibrosis and other myeloproliferative diseases. Scand J Haematol 1981;26:339-344.

Bennett JS - Mechanisms of platelet adhesion and aggregation: an update. Hosp Pract 1992;27:124-140,

Yardumian DA, Mackie IJ, Machin SJ - Laboratory investigation of platelet function: a review of methodology. J Clin Pathol 1986;39:701-712.

Baker RI & Manoharan A - Platelet function in myeloproliferative disorders: characterization and sequential studies show multiple platelet abnormalities and change with time. Eur J Haematol 1988;40:267-272.

Phadke K, Dean S, Pitney WR - Platelet dysfunction in myeloproliferative syndromes. Am J Hematol 1981;10:57-64.

Downloads

Published

1997-11-11

How to Cite

1.
Vignal CV, Lourenço DM, Noguti MAE, Chauffaille M de LF, Kerbauy J. Hemorrhagic and thrombotic complications in patients with myeloproliferative diseases. Sao Paulo Med J [Internet]. 1997 Nov. 11 [cited 2025 Mar. 21];115(6):1575-9. Available from: https://periodicosapm.emnuvens.com.br/spmj/article/view/2169

Issue

Section

Original Article